Learn More
Invivogen Imiquimod VacciGrade, 5 mg

Supplier: Invivogen VACIMQ
The imidazoquinoline compound Imiquimod is a guanosine derivative and agonist for TLR7. This TLR7 agonist, originally developed as type I IFN inducers, is an effective adjuvant by activating dendritic cells (DCs) and B cells to induce cytokines optimal for Th1 cell immunity, and antibody production.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.